Fulgent Genetics, INC Form 4 insider transactions
NASDAQ
CEO Ming Hsieh reports acquisition and disposal of Fulgent Genetics stock due to vesting of restricted stock units and tax obligations.
NASDAQ
Jian Xie, President and COO of Fulgent Genetics, reports the acquisition and disposal of company stock, including shares vesting from performance-based restricted stock units and shares withheld for tax obligations.
NASDAQ
CFO of Fulgent Genetics, Paul Kim, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Jian Xie, President and COO of Fulgent Genetics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
CEO Ming Hsieh reports disposition of Fulgent Genetics shares to cover tax obligations from vesting restricted stock units.